Intrexon Raises $66.9M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Intrexon has raised $66.9 million, according to a document filed with the US Securities and Exchange Commission last week.

Based in Blacksburg, Va., the genetic engineering firm did not say how the funds will be used but said the offering was not made in connection with a business combination transaction such as a merger.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.